AEGiS-LT: A World War on Disease: The global surge in infections demands that Congress quickly and generously fund treatment and prevention programs.

Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

A World War on Disease: The global surge in infections demands that Congress quickly and generously fund treatment and prevention programs.

Los Angeles Times - Monday, April 17, 2000

At a congressional hearing last week, Dr. Nils Daulaire, the president of the Global Health Council, told legislators that treatable infectious diseases have become the leading cause of death worldwide and contended that "not acting when you have the ability to act is an act of immorality." Bipartisan support is indeed growing for bills that would greatly expand U.S. funding of global health programs like vaccination drives, but high moral principles alone are not driving the support. The history of AIDS, last year's outbreak of West Nile encephalitis in New York and the resurfacing of tuberculosis in parts of the United States have shown that, in our global age, infectious diseases are not contained by seas and continents.

A newly declassified National Intelligence Council report recommends that the United States place global disease prevention at the center of its national security agenda, not only because the diseases could infect U.S. citizens but because they weaken the global economy. Forty-two percent of U.S. exports now go to poor countries, and their ability to buy such goods diminishes with the spread of infectious disease.

Congress' first step should be to pass a popular bipartisan bill by Reps. Sherrod Brown (D-Ohio) and Constance A. Morella (R-Md.) that would authorize $100 million in U.S. funding to nations with the most tuberculosis, such as India and countries in sub-Saharan Africa. Currently, TB kills more than 2 million people annually and the bacteria that cause the disease now infect one-third of the world's population. The funds would set up six-month-long treatment programs costing from $20 to $100 per person. That's hardly enough to cure all infections, but as World Health Organization President Gro Brundtland told legislators, the commitment would inspire other developed nations to follow suit.

This week legislators are slated to discuss a more ambitious bill by Sen. Patrick J. Leahy (D-Vt.) that would double the $1 billion the United States now spends on infectious disease programs in poor countries.

Legislators will legitimately debate the level of the increase, but whatever the dollar amount, Congress should make sure the money gets to programs that have two key features:

* Sharp oversight. Nations should be required to commit to specific targets for health care improvement and allow international observers to ensure that the money is actually used for vaccines and treatments.

* Culture-specific designs. When it began a campaign to reduce infant mortality in Bangladesh in 1980, the World Bank noted the sky-high illiteracy rate and the fact that Bangladesh could spend only $4 per person per year on health. The bank, instead of relying on physicians, developed networks of health practitioners who fanned out in villages and urban slums. The infant mortality rate dropped by nearly one-half between 1980 and 1997.

As the presence of corporation heads and Treasury Secretary Lawrence Summers at last week's hearing indicated, fighting global disease is not only an idealistic crusade. It is also a fiscal and national security imperative.

000417
LT000403

Copyright © 2000 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .